drugset / Trial / NCT07808957

Randomized Evaluation of Indocyanine Green Fluorescence Angiography-Guided Versus Standard Clinical Perfusion Assessment During Gluteal Permanent Synthetic Filler Removal

NCT07808957 ↗

Not yet recruiting 300 enrolled Research Inc
RandomizedParallel-groupTriple-blindPrevention

Summary

This randomized clinical trial will compare indocyanine green fluorescence angiography-guided assessment with standard clinical assessment of gluteal flap perfusion during removal of permanent synthetic fillers. Participants will be assigned 1:1 to fluorescence-guided or standard management. The primary outcome is the occurrence of flap ischemia, ischemia-related wound dehiscence, or tissue necrosis through postoperative day 30. Dye-related adverse reactions, management changes, wound healing, infection, and reoperation will also be evaluated.

Timeline

Start
2026-10-01
Primary completion
2026-12-01
Completion
2027-10-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Indocyanine Green Diagnostic / imaging agent 0.05 mg/kg Intravenous

Indications

No indication recorded.